Pharma Talks: AI-Driven Pharma – Turning Data Into Discovery
Description
In this episode of Pharma Talks, Nataliya Andreychuk, CEO of Viseven, welcomes Alejandro Jaramillo, Head of Data Science, Insights & Analytics to discuss how AI-driven pharma decisions are redefining every aspect of the pharmaceutical industry.
Together, they dive deep into how AI-driven pharmaceutical innovation is helping organizations move beyond simple dashboards toward predictive, data-led decision-making. They explore how AI in pharma enables smarter forecasting, improves drug development automation, and supports a more patient-centric approach – all while staying compliant with regulatory frameworks like HIPAA and GDPR.
Key topics explored in this episode:
• The shift from descriptive analytics to AI-driven decision-making in pharma.
• How predictive analytics and real-world evidence enhance outcomes across the pharma digital ecosystem.
• Managing ethical AI in healthcare and ensuring pharma data governance in a regulated environment.
• The evolution of next-gen pharma leadership – why empathy, collaboration, and data fluency define future-ready leaders.
• The role of AI personalization in simplifying engagement with HCPs and patients while maintaining compliance.
Tune in now!
Contact Viseven experts to elevate your healthcare marketing strategy:
https://viseven.com/contact-us/
***
Follow Viseven, Nataliya, and Alejandro in social media:
https://www.linkedin.com/company/viseven/
https://www.linkedin.com/in/andreychuk/
https://www.linkedin.com/in/aljaramillo/
***
Case studies mentioned by Alejandro:
https://www.aktana.com/resources/case-study-nba-activation/?utm_source=chatgpt.com
https://www.nature.com/articles/s41598-021-98387-w?utm_source=chatgpt.com
***
🔗 Links for more insights:
https://viseven.com/healthcare-data-analytics/
https://viseven.com/ai-powered-analytics-for-life-sciences-marketing/
United States
